Internal Medicine · Mobile, AL
NPI
1306844394
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3715 Dauphin St, Suite 7a
Mobile, AL, 36608
Phone (251) 410-4001
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
1,902 services
Medicare patients, 2024
321
Average age 75
Drug cost, 2024
$4.1M
19,941 prescriptions
Company payments, 2025
$3,910
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas G McKelvey was code 36415 (venipuncture blood collection), 710 times for 305 patients. In total Thomas G McKelvey billed 1,902 services in 43 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-05-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 710 | 305 | $8.22 | $5,834 |
| 99214 Office E&M - Established | Office | 527 | 288 | $75.24 | $40K |
| 96372 Injection Administration | Office | 69 | 19 | $8.56 | $591 |
| G0008 Administration of influenza virus vaccine | Office | 53 | 53 | $28.90 | $1,532 |
| 90662 Vaccine Product | Office | 50 | 50 | $81.82 | $4,091 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 24 | 22 | $36.09 | $866 |
| 95251 Test - Miscellaneous | Office | 23 | 13 | $23.96 | $551 |
| 99204 Office E&M - New | Office | 17 | 17 | $102.24 | $1,738 |
| 93000 Electrocardiogram | Office | 16 | 16 | $7.77 | $124 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 12 | 11 | $0.60 | $7.17 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 12 | 12 | $10.45 | $125 |
| 99213 Office E&M - Established | Office | 11 | 11 | $61.61 | $678 |
By year: 2022 $69K for 2,186 services; 2023 $65K for 2,422 services; 2024 $60K for 1,902 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 710 | 305 | $8.22 | $5,834 |
Medicare prescription drug claims, 2024
In 2024, the drug Thomas G McKelvey prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,206 prescriptions and refills. In total Thomas G McKelvey wrote 19,941 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,206 | 3,516 | 374 | $15K |
| Ezetimibe Generic | 1,046 | 2,990 | 323 | $22K |
| Rosuvastatin Calcium Generic | 884 | 2,555 | 265 | $15K |
| Amlodipine Besylate Generic | 670 | 1,933 | 208 | $4,288 |
| Valsartan Generic | 634 | 1,782 | 193 | $19K |
| Ozempic Semaglutide | 619 | 1,168 | 162 | $1.1M |
| Famotidine Generic | 575 | 1,628 | 180 | $12K |
| Levothyroxine Sodium Generic | 571 | 1,668 | 156 | $6,397 |
| Metformin Hcl Er Metformin Hcl | 548 | 1,576 | 189 | $7,742 |
| Mounjaro Tirzepatide | 434 | 500 | 73 | $521K |
| Farxiga Dapagliflozin Propanediol | 430 | 902 | 122 | $505K |
| Omeprazole Generic | 426 | 1,220 | 132 | $7,688 |
| Irbesartan Generic | 360 | 1,055 | 104 | $8,388 |
| Pantoprazole Sodium Generic | 358 | 1,035 | 123 | $5,183 |
| Losartan Potassium Generic | 334 | 984 | 106 | $3,795 |
Brand drugs: 3,764 claims; generic drugs: 16,009 claims; opioid claims: 45.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas G McKelvey $3,910 ($3,910 in general payments such as food, travel and fees) from 17 companies. The largest payer was Novo Nordisk Inc with $2,302.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 32 | $2,302 |
| Amgen Inc. AMGN | 48 | $397 |
| Abbvie Inc. ABBV | 8 | $221 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $172 |
| Sumitomo Pharma America, Inc. 4506.T | 11 | $161 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $157 |
| Lilly USA, LLC LLY | 9 | $125 |
| Abbott Laboratories ABT | 4 | $66.85 |
| Xeris Pharmaceuticals, Inc. | 3 | $63.76 |
| GlaxoSmithKline, LLC. GSK | 3 | $54.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.